Intestinal Microsporidia Infection in Leukemic Children: Microscopic and Molecular Detection

Amel Youssef Shehab1, Esraa Abdelhamid Moneer2, Amal Farahat Allam3

  • 1Department of Parasitology, Medical Research Institute, University of Alexandria, 165 El Horreya Avenue, El Hadara, Alexandria, Egypt. shehab.amel@gmail.com.

Acta Parasitologica
|September 30, 2020
PubMed
Abstract

Insights

Microsporidia infection is prevalent in leukemic children, with PCR offering superior detection and speciation compared to modified trichrome stain. Diarrhea and colic were linked to infection in this vulnerable group.

Area of Science:

  • Medical Parasitology
  • Molecular Diagnostics
  • Pediatric Oncology

Background:

  • Microsporidia are opportunistic pathogens, historically linked to immunocompromised individuals.
  • Microscopic diagnosis of microsporidia is challenging due to their small size, even for expert microscopists.

Purpose of the Study:

  • To investigate the prevalence of microsporidia infection in children undergoing chemotherapy for leukemia.
  • To evaluate the diagnostic performance of modified trichrome stain (MTS) and polymerase chain reaction (PCR) for microsporidia detection and speciation.

Main Methods:

  • Microscopic examination of stool samples from 100 leukemic children using MTS.
  • DNA extraction followed by conventional and nested PCR for microsporidia detection.
  • PCR amplification and DNA sequencing for species identification of positive samples.

Main Results:

  • Microsporidia were detected in 23% of children by MTS and 29% by PCR.
  • Enterocytozoon bieneusi was the predominant species (20 cases), followed by Encephalitozoon intestinalis (3 cases).
  • PCR demonstrated higher sensitivity (72.4%) and accuracy (90%) than MTS, with diarrhea and colic associated with infection.

Conclusions:

  • Sensitive molecular tools like PCR are crucial for accurate microsporidiosis prevalence determination.
  • Species identification aids in understanding potential transmission sources of microsporidia in immunocompromised patients.